Find clinical trials for Pancreatic Cancer in Paris, Île-de-France
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Pancreatic Cancer trials near Paris, Île-de-France, FRA:
Zolbetuximab is being studied as a treatment for people with pancreatic cancer. Most people with pancreatic cancer...
Phase 2
Villejuif, Villejuif Cedex, France and 135 other locations
SOT102 administered as monotherapy (Part C) and in combination with first-line SoC treatment (Part D) in patients with advanced or metastatic pancreatic...
Phase 1, Phase 2
Paris, France and 7 other locations
phosphorylase (MTAP)-deleted gastrointestinal, biliary tract, or pancreatic cancers. The study also aims to determine the safety pr...
Phase 1
Villejuif, France and 55 other locations
Phase 1b/2 study to assess the safety and efficacy of mitazalimab in combination with chemotherapy in patients with metastatic pancreatic du...
Phase 1, Phase 2
Paris, France and 13 other locations
to participants. Part C will use the information from Parts A and B to see if PF-08046049/SGN-BB228 is safe and if it works to treat solid tumor...
Phase 1
Villejuif Cedex, Other, France and 21 other locations
This study is open to adults with advanced pancreatic cancer for whom previous treatment was not successful or no treatment exists. ...
Phase 1
Villejuif, France and 13 other locations
This trial will study tisotumab vedotin to find out whether it is an effective treatment alone or with other anticancer drugs for certain solid tumors...
Phase 2
Villejuif Cedex, Other, France and 71 other locations
Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects with Gastrointestinal, Pancreatic, or Colorectal Cancer...
Phase 3
Paris, France and 116 other locations
concept to independently and simultaneously assess the effects of the association of atezolizumab + BDB001 + radiotherapy in multiple solid tumors...
Phase 2
Paris, France and 10 other locations
to assess the safety, tolerability, PK, PD, immunogenicity and anti-tumor activity of zenocutuzumab (MCLA-128) in patients with solid tumors...
Phase 2
Paris, France and 64 other locations
Clinical trials
Research sites
Resources
Legal